COVID-19 Archives
VUMC creates new Adult Post-acute COVID Clinic
Apr. 8, 2021—On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.
COVID-19 lessons: VUMC, other hospital leaders pinpoint opportunities in National Academy Review
Apr. 7, 2021—The versatility of health systems in the national COVID-19 response underscore the challenges and opportunities for leaders to strengthen and design systems to better care for communities and respond to ever-changing needs, top health care delivery system leaders outline in a discussion paper for the National Academy of Medicine (NAM).
U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC
Apr. 6, 2021—The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.
Investigational vaccine to be tested against COVID-19 variant
Apr. 2, 2021—Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.
COVID-19 met with intensive teamwork
Apr. 1, 2021—Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts.
COVID recovery included long stay on ECMO, double-lung transplant
Apr. 1, 2021—Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.
Study shows new COVID target could improve vaccines
Apr. 1, 2021—Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus.
Monroe Carell Jr. Children’s Hospital at Vanderbilt selected as trial site for pediatric COVID-19 vaccine
Mar. 30, 2021—Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin a phase 2/3 clinical trial to study the safety and efficacy of the Moderna COVID-19 vaccine in children.
Wilkins outlines COVID-19 health equity lessons to U.S. Senate
Mar. 30, 2021—Using insights from the COVID-19 response, Consuelo Wilkins, MD, MSCI, outlined to the U.S. Senate a three-pronged plan to increase health equity by prioritizing trust in communities.
COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses
Mar. 19, 2021—The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
Study to assess allergic reactions to COVID vaccines
Mar. 18, 2021—Vanderbilt University Medical Center is recruiting volunteers for a randomized controlled phase 2 clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna.
Preterm births in Tennessee decreased during pandemic
Mar. 15, 2021—Statewide stay-at-home orders put in place as Tennessee fought to control the spread of coronavirus last March were associated with a 14% lower rate of preterm birth, according to a research letter published today in JAMA Pediatrics.